

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.90358769 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.90358769 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.56905747 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.56905747 |
| 5 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.78222708 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73888801 |
| 7 | glucose 6-phosphate metabolic process (GO:0051156) | 4.54790953 |
| 8 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.37831426 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.35921071 |
| 10 | cellular response to interferon-beta (GO:0035458) | 4.35003521 |
| 11 | thrombin receptor signaling pathway (GO:0070493) | 4.29084716 |
| 12 | axonemal dynein complex assembly (GO:0070286) | 4.25091090 |
| 13 | intestinal epithelial cell development (GO:0060576) | 4.22914560 |
| 14 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.96359130 |
| 15 | GDP-mannose metabolic process (GO:0019673) | 3.93385477 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87268669 |
| 17 | protein retention in ER lumen (GO:0006621) | 3.81336915 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80969717 |
| 19 | COPII vesicle coating (GO:0048208) | 3.79033100 |
| 20 | endocrine pancreas development (GO:0031018) | 3.76816925 |
| 21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.74810610 |
| 22 | glandular epithelial cell differentiation (GO:0002067) | 3.73894696 |
| 23 | intestinal absorption (GO:0050892) | 3.71655695 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.67857196 |
| 25 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.67211836 |
| 26 | leukotriene biosynthetic process (GO:0019370) | 3.65705191 |
| 27 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.63996234 |
| 28 | negative regulation of bone resorption (GO:0045779) | 3.55646290 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.52641487 |
| 30 | peptide hormone processing (GO:0016486) | 3.49925397 |
| 31 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.45775614 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43448649 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40363744 |
| 34 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.36002296 |
| 35 | protein targeting to ER (GO:0045047) | 3.35053100 |
| 36 | cotranslational protein targeting to membrane (GO:0006613) | 3.30682023 |
| 37 | signal peptide processing (GO:0006465) | 3.29847695 |
| 38 | response to interferon-beta (GO:0035456) | 3.29602885 |
| 39 | positive regulation of nuclease activity (GO:0032075) | 3.27422966 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23662952 |
| 41 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.19856047 |
| 42 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.18269822 |
| 43 | sequestering of metal ion (GO:0051238) | 3.17660564 |
| 44 | protein localization to endoplasmic reticulum (GO:0070972) | 3.17380694 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.17179661 |
| 46 | protein maturation by protein folding (GO:0022417) | 3.16074617 |
| 47 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.10316715 |
| 48 | lipoxygenase pathway (GO:0019372) | 3.08180206 |
| 49 | response to peptidoglycan (GO:0032494) | 3.08035769 |
| 50 | motile cilium assembly (GO:0044458) | 3.06913350 |
| 51 | definitive hemopoiesis (GO:0060216) | 3.06809594 |
| 52 | regulation of nuclease activity (GO:0032069) | 3.06441441 |
| 53 | pyrimidine-containing compound salvage (GO:0008655) | 3.04931356 |
| 54 | pyrimidine nucleoside salvage (GO:0043097) | 3.04931356 |
| 55 | ribosomal small subunit assembly (GO:0000028) | 3.03107036 |
| 56 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.03027184 |
| 57 | intestinal cholesterol absorption (GO:0030299) | 3.01804653 |
| 58 | positive regulation of insulin secretion (GO:0032024) | 3.01307518 |
| 59 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.97701959 |
| 60 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.97701959 |
| 61 | cellular response to unfolded protein (GO:0034620) | 2.96493461 |
| 62 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.95834072 |
| 63 | cilium movement (GO:0003341) | 2.95321664 |
| 64 | peptide catabolic process (GO:0043171) | 2.94611317 |
| 65 | nucleotide salvage (GO:0043173) | 2.93324915 |
| 66 | B cell mediated immunity (GO:0019724) | 2.91163541 |
| 67 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.86516626 |
| 68 | cellular response to topologically incorrect protein (GO:0035967) | 2.86396956 |
| 69 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.84225292 |
| 70 | adaptation of signaling pathway (GO:0023058) | 2.84115620 |
| 71 | regulation of integrin activation (GO:0033623) | 2.83301925 |
| 72 | angiotensin maturation (GO:0002003) | 2.82815833 |
| 73 | growth hormone receptor signaling pathway (GO:0060396) | 2.82607745 |
| 74 | viral transcription (GO:0019083) | 2.79835227 |
| 75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79059507 |
| 76 | positive regulation of type 2 immune response (GO:0002830) | 2.78224033 |
| 77 | vesicle coating (GO:0006901) | 2.77328996 |
| 78 | detection of bacterium (GO:0016045) | 2.77124240 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76971120 |
| 80 | germinal center formation (GO:0002467) | 2.76907450 |
| 81 | regulation of cellular extravasation (GO:0002691) | 2.75966613 |
| 82 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.75778113 |
| 83 | regulation of respiratory burst (GO:0060263) | 2.73732534 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 2.73004639 |
| 85 | regulation of RIG-I signaling pathway (GO:0039535) | 2.71925383 |
| 86 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.71556100 |
| 87 | regulation of mast cell degranulation (GO:0043304) | 2.69910977 |
| 88 | negative regulation of cell killing (GO:0031342) | 2.69555858 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69555858 |
| 90 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.69429629 |
| 91 | positive thymic T cell selection (GO:0045059) | 2.69314304 |
| 92 | translational termination (GO:0006415) | 2.68878001 |
| 93 | protein autoprocessing (GO:0016540) | 2.68826258 |
| 94 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68274167 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67739100 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 2.67739100 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67739100 |
| 98 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67739100 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67739100 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 2.67739100 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67545825 |
| 102 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67434310 |
| 103 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.66765341 |
| 104 | ER-nucleus signaling pathway (GO:0006984) | 2.66642864 |
| 105 | response to type I interferon (GO:0034340) | 2.65994881 |
| 106 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.65670337 |
| 107 | response to host immune response (GO:0052572) | 2.65258321 |
| 108 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65258321 |
| 109 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65065218 |
| 110 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.64389889 |
| 111 | amyloid precursor protein catabolic process (GO:0042987) | 2.64296912 |
| 112 | nucleotide-sugar metabolic process (GO:0009225) | 2.64294430 |
| 113 | negative regulation of granulocyte differentiation (GO:0030853) | 2.64173893 |
| 114 | peptidyl-asparagine modification (GO:0018196) | 2.62743817 |
| 115 | hepatocyte apoptotic process (GO:0097284) | 2.62385659 |
| 116 | type I interferon signaling pathway (GO:0060337) | 2.62288955 |
| 117 | cellular response to type I interferon (GO:0071357) | 2.62288955 |
| 118 | negative regulation of bone remodeling (GO:0046851) | 2.62278070 |
| 119 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60845579 |
| 120 | regulation of leukocyte degranulation (GO:0043300) | 2.59931920 |
| 121 | epithelial structure maintenance (GO:0010669) | 2.59919557 |
| 122 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.59141718 |
| 123 | UMP biosynthetic process (GO:0006222) | 2.59141718 |
| 124 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.59141718 |
| 125 | UMP metabolic process (GO:0046049) | 2.59141718 |
| 126 | sperm motility (GO:0030317) | 2.58628889 |
| 127 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58272843 |
| 128 | regulation of antigen processing and presentation (GO:0002577) | 2.58196235 |
| 129 | detection of other organism (GO:0098543) | 2.57923228 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.57896865 |
| 131 | trophectodermal cell differentiation (GO:0001829) | 2.57190865 |
| 132 | carbohydrate phosphorylation (GO:0046835) | 2.56847481 |
| 133 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.56541447 |
| 134 | epithelial cilium movement (GO:0003351) | 2.54931294 |
| 135 | cellular zinc ion homeostasis (GO:0006882) | 2.53652683 |
| 136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52787666 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52440566 |
| 138 | regulation of cholesterol homeostasis (GO:2000188) | 2.51252162 |
| 139 | positive regulation of peptide hormone secretion (GO:0090277) | 2.50799018 |
| 140 | antimicrobial humoral response (GO:0019730) | 2.50705575 |
| 141 | neutrophil activation (GO:0042119) | 2.50093915 |
| 142 | regulation of interleukin-13 production (GO:0032656) | 2.49137279 |
| 143 | phospholipid scrambling (GO:0017121) | 2.48840890 |
| 144 | sexual reproduction (GO:0019953) | 2.47404272 |
| 145 | antibacterial humoral response (GO:0019731) | 2.47225204 |
| 146 | translational elongation (GO:0006414) | 2.46548854 |
| 147 | N-acetylneuraminate metabolic process (GO:0006054) | 2.46261025 |
| 148 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.46085802 |
| 149 | nucleoside salvage (GO:0043174) | 2.46033158 |
| 150 | sperm capacitation (GO:0048240) | 2.44787786 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.44388288 |
| 152 | regulation of germinal center formation (GO:0002634) | 2.42594793 |
| 153 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41927828 |
| 154 | cellular response to exogenous dsRNA (GO:0071360) | 2.41207610 |
| 155 | GMP metabolic process (GO:0046037) | 2.40221840 |
| 156 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.39675674 |
| 157 | response to endoplasmic reticulum stress (GO:0034976) | 2.37514667 |
| 158 | viral life cycle (GO:0019058) | 2.37277220 |
| 159 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.36417098 |
| 160 | protein N-linked glycosylation (GO:0006487) | 2.34988615 |
| 161 | leukotriene metabolic process (GO:0006691) | 2.34946198 |
| 162 | receptor recycling (GO:0001881) | 2.34826749 |
| 163 | cellular response to growth hormone stimulus (GO:0071378) | 2.34795464 |
| 164 | response to host (GO:0075136) | 2.34197852 |
| 165 | response to host defenses (GO:0052200) | 2.34197852 |
| 166 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34197852 |
| 167 | response to muramyl dipeptide (GO:0032495) | 2.32175003 |
| 168 | defense response to protozoan (GO:0042832) | 2.31990298 |
| 169 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.31656228 |
| 170 | actin nucleation (GO:0045010) | 2.30835700 |
| 171 | regulation of interleukin-4 production (GO:0032673) | 2.30350182 |
| 172 | histone H3-K36 demethylation (GO:0070544) | 2.29472241 |
| 173 | axoneme assembly (GO:0035082) | 2.27762427 |
| 174 | B cell homeostasis (GO:0001782) | 2.27437088 |
| 175 | regulation of regulated secretory pathway (GO:1903305) | 2.26387286 |
| 176 | response to protozoan (GO:0001562) | 2.25802386 |
| 177 | regulation of guanylate cyclase activity (GO:0031282) | 2.25332178 |
| 178 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.23269839 |
| 179 | Peyers patch development (GO:0048541) | 2.23269839 |
| 180 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.23123830 |
| 181 | macrophage activation involved in immune response (GO:0002281) | 2.22489124 |
| 182 | actin filament polymerization (GO:0030041) | 2.22326329 |
| 183 | amyloid precursor protein metabolic process (GO:0042982) | 2.21945451 |
| 184 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.20066613 |
| 185 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.19793713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.23370562 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.96316444 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.84259431 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.54942266 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.51655605 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24643078 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19901012 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17086186 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15040672 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12098973 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07391997 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.06487614 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04710157 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96875060 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94626706 |
| 16 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89023297 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88259492 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.86589658 |
| 19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85477952 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84377444 |
| 21 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.81504719 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77553786 |
| 23 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73276986 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71478046 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.70593579 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.66613592 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65885851 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63137051 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62991189 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.61895948 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60676544 |
| 32 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59694150 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59531840 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.57884873 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57773522 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57150066 |
| 37 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.54101950 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53758893 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53465849 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.50451062 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50074310 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49908981 |
| 43 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47135193 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46669894 |
| 45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46645537 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46537770 |
| 47 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.46343699 |
| 48 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45692848 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.45575715 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45307903 |
| 51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44683873 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43451065 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41076249 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39464000 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39383901 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37927178 |
| 57 | MYB_26560356_Chip-Seq_TH1_Human | 1.36866461 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.36284423 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36124344 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35963056 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.34588698 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34444917 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33285555 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32544879 |
| 65 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.32539905 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32317267 |
| 67 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31932867 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31124940 |
| 69 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30632449 |
| 70 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30230608 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30200012 |
| 72 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.29233529 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28362762 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28033628 |
| 75 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27510591 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26900332 |
| 77 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.26700936 |
| 78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26041129 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25373367 |
| 80 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24951809 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24813833 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24089112 |
| 83 | P300_27268052_Chip-Seq_Bcells_Human | 1.23487957 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23338947 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23246596 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.22796897 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22408300 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21915035 |
| 89 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20629813 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20122203 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19998410 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19920800 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18914582 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18326529 |
| 95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17558000 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17240001 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16520060 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16006942 |
| 99 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15849457 |
| 100 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14541007 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14195818 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14058744 |
| 103 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13942894 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13471243 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13236239 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 1.13065672 |
| 107 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12929098 |
| 108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12920555 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12656581 |
| 110 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11603691 |
| 111 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11569829 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10883786 |
| 113 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09830330 |
| 114 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09537406 |
| 115 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09014197 |
| 116 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.08877298 |
| 117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08325111 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07688279 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07495793 |
| 120 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07074409 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07030863 |
| 122 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06758494 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06253615 |
| 124 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.06069701 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05545234 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04884401 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04382353 |
| 128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04351896 |
| 129 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04127717 |
| 130 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03828868 |
| 131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03741647 |
| 132 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03684021 |
| 133 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02878071 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02410738 |
| 135 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02166894 |
| 136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01938824 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01459988 |
| 138 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01344021 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00994938 |
| 140 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00822183 |
| 141 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00153817 |
| 142 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99868025 |
| 143 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98801627 |
| 144 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98789446 |
| 145 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98587779 |
| 146 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98162422 |
| 147 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97821091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.70981751 |
| 2 | MP0003183_abnormal_peptide_metabolism | 3.38160913 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 2.95906966 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 2.87406869 |
| 5 | MP0003866_abnormal_defecation | 2.84460278 |
| 6 | MP0003303_peritoneal_inflammation | 2.74579691 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.64971827 |
| 8 | MP0009840_abnormal_foam_cell | 2.50449134 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.46442451 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.35746680 |
| 11 | MP0001873_stomach_inflammation | 2.34743779 |
| 12 | MP0002693_abnormal_pancreas_physiology | 2.28382876 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.19770344 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.19294895 |
| 15 | MP0005410_abnormal_fertilization | 2.13262523 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.11576099 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.04401992 |
| 18 | MP0000685_abnormal_immune_system | 2.01578031 |
| 19 | MP0009278_abnormal_bone_marrow | 1.93722874 |
| 20 | MP0005671_abnormal_response_to | 1.91384994 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.84579909 |
| 22 | MP0001944_abnormal_pancreas_morphology | 1.82631257 |
| 23 | MP0003283_abnormal_digestive_organ | 1.82455742 |
| 24 | MP0005379_endocrine/exocrine_gland_phen | 1.78392025 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.76798428 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.76798428 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.71528721 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.71186405 |
| 29 | MP0005365_abnormal_bile_salt | 1.71065986 |
| 30 | MP0000490_abnormal_crypts_of | 1.68770429 |
| 31 | MP0002132_abnormal_respiratory_system | 1.65510114 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.64636916 |
| 33 | MP0002822_catalepsy | 1.58179909 |
| 34 | MP0001881_abnormal_mammary_gland | 1.57248603 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.57200977 |
| 36 | MP0005451_abnormal_body_composition | 1.56980077 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.53199829 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.51630437 |
| 39 | MP0004947_skin_inflammation | 1.50869897 |
| 40 | MP0000462_abnormal_digestive_system | 1.50329280 |
| 41 | MP0005310_abnormal_salivary_gland | 1.49704044 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.48160306 |
| 43 | MP0004043_abnormal_pH_regulation | 1.43458729 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.43128950 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.42791355 |
| 46 | MP0001800_abnormal_humoral_immune | 1.42177374 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.40494566 |
| 48 | MP0006054_spinal_hemorrhage | 1.38244652 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.37105805 |
| 50 | MP0003436_decreased_susceptibility_to | 1.35195339 |
| 51 | MP0001765_abnormal_ion_homeostasis | 1.34186724 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.32616313 |
| 53 | MP0000015_abnormal_ear_pigmentation | 1.31711218 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.28404159 |
| 55 | MP0002723_abnormal_immune_serum | 1.26620676 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.26274631 |
| 57 | MP0001790_abnormal_immune_system | 1.26012935 |
| 58 | MP0005387_immune_system_phenotype | 1.26012935 |
| 59 | MP0002405_respiratory_system_inflammati | 1.25580242 |
| 60 | MP0002398_abnormal_bone_marrow | 1.24490578 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.23553330 |
| 62 | MP0005025_abnormal_response_to | 1.23300043 |
| 63 | MP0001819_abnormal_immune_cell | 1.23139159 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.21305399 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.20957187 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.20912086 |
| 67 | MP0000477_abnormal_intestine_morphology | 1.20763786 |
| 68 | MP0005083_abnormal_biliary_tract | 1.20452868 |
| 69 | MP0001756_abnormal_urination | 1.19733233 |
| 70 | MP0001849_ear_inflammation | 1.19628743 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.19443013 |
| 72 | MP0004510_myositis | 1.19272384 |
| 73 | MP0002796_impaired_skin_barrier | 1.19075261 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.18495002 |
| 75 | MP0000716_abnormal_immune_system | 1.17208570 |
| 76 | MP0001663_abnormal_digestive_system | 1.15325574 |
| 77 | MP0009764_decreased_sensitivity_to | 1.14804089 |
| 78 | MP0000538_abnormal_urinary_bladder | 1.12955232 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.12617093 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 1.11741782 |
| 81 | MP0003868_abnormal_feces_composition | 1.10797265 |
| 82 | MP0005166_decreased_susceptibility_to | 1.10689133 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 1.10403232 |
| 84 | MP0003787_abnormal_imprinting | 1.10021440 |
| 85 | MP0005409_darkened_coat_color | 1.09942007 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 1.09901745 |
| 87 | MP0002653_abnormal_ependyma_morphology | 1.09481314 |
| 88 | MP0002722_abnormal_immune_system | 1.08102782 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 1.07131167 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.07046663 |
| 91 | MP0009785_altered_susceptibility_to | 1.06964565 |
| 92 | MP0005085_abnormal_gallbladder_physiolo | 1.06609781 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 1.05750889 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 1.05622266 |
| 95 | MP0004957_abnormal_blastocyst_morpholog | 1.05068541 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 1.04524158 |
| 97 | MP0000003_abnormal_adipose_tissue | 1.04500909 |
| 98 | MP0002429_abnormal_blood_cell | 1.03535174 |
| 99 | MP0000689_abnormal_spleen_morphology | 1.02839864 |
| 100 | MP0000609_abnormal_liver_physiology | 0.99875853 |
| 101 | MP0000703_abnormal_thymus_morphology | 0.96401447 |
| 102 | MP0005535_abnormal_body_temperature | 0.95342024 |
| 103 | MP0004019_abnormal_vitamin_homeostasis | 0.94670010 |
| 104 | MP0003879_abnormal_hair_cell | 0.94017002 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.93106012 |
| 106 | MP0000613_abnormal_salivary_gland | 0.92463806 |
| 107 | MP0001664_abnormal_digestion | 0.92127032 |
| 108 | MP0005645_abnormal_hypothalamus_physiol | 0.89736862 |
| 109 | MP0003191_abnormal_cellular_cholesterol | 0.89611482 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.88398087 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.88150872 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.87694642 |
| 113 | MP0003718_maternal_effect | 0.85095961 |
| 114 | MP0008469_abnormal_protein_level | 0.83244113 |
| 115 | MP0002419_abnormal_innate_immunity | 0.83196015 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.83022591 |
| 117 | MP0008874_decreased_physiological_sensi | 0.81611536 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.81077647 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.79405167 |
| 120 | MP0003724_increased_susceptibility_to | 0.78258697 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.77648776 |
| 122 | MP0000470_abnormal_stomach_morphology | 0.77570590 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.77415742 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.77232293 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.76852687 |
| 126 | MP0005360_urolithiasis | 0.75798011 |
| 127 | MP0000627_abnormal_mammary_gland | 0.74554280 |
| 128 | MP0003075_altered_response_to | 0.74133376 |
| 129 | MP0008004_abnormal_stomach_pH | 0.73374602 |
| 130 | MP0003953_abnormal_hormone_level | 0.72708462 |
| 131 | MP0002095_abnormal_skin_pigmentation | 0.70859181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysostosis multiplex (HP:0000943) | 5.38778428 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.58290422 |
| 3 | Mucopolysacchariduria (HP:0008155) | 4.36213872 |
| 4 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.36213872 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.16245591 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 4.12087355 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.12087355 |
| 8 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.08993213 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.00037440 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.00037440 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.00037440 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.99644253 |
| 13 | Hypoglycemic seizures (HP:0002173) | 3.95410469 |
| 14 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.93425881 |
| 15 | Abnormal ciliary motility (HP:0012262) | 3.92442639 |
| 16 | Late onset (HP:0003584) | 3.91077585 |
| 17 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.89698616 |
| 18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.89698616 |
| 19 | Symptomatic seizures (HP:0011145) | 3.80303830 |
| 20 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.65948408 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.35926446 |
| 22 | Bronchiectasis (HP:0002110) | 3.29679040 |
| 23 | Rhinitis (HP:0012384) | 3.26825705 |
| 24 | Petechiae (HP:0000967) | 3.25175609 |
| 25 | Recurrent sinusitis (HP:0011108) | 3.19892428 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.05535285 |
| 27 | Thrombocytosis (HP:0001894) | 3.02129516 |
| 28 | Purpura (HP:0000979) | 3.01027791 |
| 29 | Decreased circulating renin level (HP:0003351) | 2.98274087 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.94416095 |
| 31 | Epistaxis (HP:0000421) | 2.92649768 |
| 32 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90940985 |
| 33 | Abdominal distention (HP:0003270) | 2.90288720 |
| 34 | Agammaglobulinemia (HP:0004432) | 2.89292257 |
| 35 | Hyperglycemia (HP:0003074) | 2.83841588 |
| 36 | Colitis (HP:0002583) | 2.80045259 |
| 37 | Gingival bleeding (HP:0000225) | 2.78255561 |
| 38 | Abnormality of B cell number (HP:0010975) | 2.78132627 |
| 39 | B lymphocytopenia (HP:0010976) | 2.78132627 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.77953206 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.77369071 |
| 42 | Tubulointerstitial nephritis (HP:0001970) | 2.76123368 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.74461831 |
| 44 | IgM deficiency (HP:0002850) | 2.72163016 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71515469 |
| 46 | Ketoacidosis (HP:0001993) | 2.70122553 |
| 47 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.68759972 |
| 48 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.68759972 |
| 49 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.68291200 |
| 50 | Villous atrophy (HP:0011473) | 2.68291200 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.66417763 |
| 52 | Hypoplasia of the thymus (HP:0000778) | 2.62387235 |
| 53 | Malnutrition (HP:0004395) | 2.61630491 |
| 54 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.60169632 |
| 55 | Abnormal pancreas size (HP:0012094) | 2.57447400 |
| 56 | Increased cerebral lipofuscin (HP:0011813) | 2.56896187 |
| 57 | Chronic sinusitis (HP:0011109) | 2.55497420 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.50743613 |
| 59 | Severe short stature (HP:0003510) | 2.47112160 |
| 60 | Obstructive lung disease (HP:0006536) | 2.46940039 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46940039 |
| 62 | Cellulitis (HP:0100658) | 2.46586485 |
| 63 | Aplastic anemia (HP:0001915) | 2.46318745 |
| 64 | Pustule (HP:0200039) | 2.45907474 |
| 65 | Hyperparathyroidism (HP:0000843) | 2.44417312 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.40397361 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.40397361 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.40397361 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.40397361 |
| 70 | Meningitis (HP:0001287) | 2.37675425 |
| 71 | Thoracolumbar scoliosis (HP:0002944) | 2.37419614 |
| 72 | Vasculitis (HP:0002633) | 2.37044151 |
| 73 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.36691525 |
| 74 | Type I transferrin isoform profile (HP:0003642) | 2.36296576 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36295111 |
| 76 | Abnormal platelet volume (HP:0011876) | 2.33533472 |
| 77 | Infertility (HP:0000789) | 2.33366969 |
| 78 | Recurrent bronchitis (HP:0002837) | 2.33295279 |
| 79 | Insulin resistance (HP:0000855) | 2.33244245 |
| 80 | Abnormality of T cell physiology (HP:0011840) | 2.33053417 |
| 81 | Menorrhagia (HP:0000132) | 2.32460897 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.30566052 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30361022 |
| 84 | Hyperkalemia (HP:0002153) | 2.28433235 |
| 85 | Increased IgM level (HP:0003496) | 2.28111689 |
| 86 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.27497225 |
| 87 | Bronchitis (HP:0012387) | 2.25865682 |
| 88 | Increased IgE level (HP:0003212) | 2.25748543 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.25661037 |
| 90 | Large for gestational age (HP:0001520) | 2.25538691 |
| 91 | Nasal polyposis (HP:0100582) | 2.25516206 |
| 92 | Severe combined immunodeficiency (HP:0004430) | 2.24166037 |
| 93 | Gingivitis (HP:0000230) | 2.21967193 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 2.21011043 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 2.20405229 |
| 96 | Increased mean platelet volume (HP:0011877) | 2.19854465 |
| 97 | Stomach cancer (HP:0012126) | 2.17415623 |
| 98 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16333832 |
| 99 | Flat acetabular roof (HP:0003180) | 2.15664638 |
| 100 | Abnormality of T cells (HP:0002843) | 2.15507922 |
| 101 | Combined immunodeficiency (HP:0005387) | 2.14902535 |
| 102 | Chronic bronchitis (HP:0004469) | 2.14721287 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.13433987 |
| 104 | Chronic otitis media (HP:0000389) | 2.13336521 |
| 105 | Recurrent otitis media (HP:0000403) | 2.12418293 |
| 106 | Gout (HP:0001997) | 2.11816940 |
| 107 | Severe visual impairment (HP:0001141) | 2.11521698 |
| 108 | Myositis (HP:0100614) | 2.10932465 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10852932 |
| 110 | Abnormality of the intrinsic pathway (HP:0010989) | 2.10825270 |
| 111 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.10427602 |
| 112 | Gastrointestinal stroma tumor (HP:0100723) | 2.09912316 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 2.09551757 |
| 114 | Seborrheic dermatitis (HP:0001051) | 2.09242067 |
| 115 | Recurrent fungal infections (HP:0002841) | 2.08730993 |
| 116 | Recurrent viral infections (HP:0004429) | 2.07681975 |
| 117 | Abnormality of renin-angiotensin system (HP:0000847) | 2.04993986 |
| 118 | Homocystinuria (HP:0002156) | 2.04527053 |
| 119 | Abnormality of homocysteine metabolism (HP:0010919) | 2.04527053 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03414487 |
| 121 | Oligomenorrhea (HP:0000876) | 2.02302133 |
| 122 | Amelogenesis imperfecta (HP:0000705) | 2.01069196 |
| 123 | Chest pain (HP:0100749) | 2.00438466 |
| 124 | Abnormal platelet function (HP:0011869) | 2.00035019 |
| 125 | Impaired platelet aggregation (HP:0003540) | 2.00035019 |
| 126 | Chronic diarrhea (HP:0002028) | 1.99790539 |
| 127 | Alveolar cell carcinoma (HP:0006519) | 1.99312426 |
| 128 | Global brain atrophy (HP:0002283) | 1.99272848 |
| 129 | Stomatitis (HP:0010280) | 1.99261541 |
| 130 | Abnormal biliary tract morphology (HP:0012440) | 1.98248911 |
| 131 | Abnormality of vitamin B metabolism (HP:0004340) | 1.98017502 |
| 132 | Dysautonomia (HP:0002459) | 1.97537118 |
| 133 | Recurrent skin infections (HP:0001581) | 1.95610106 |
| 134 | Limb hypertonia (HP:0002509) | 1.93876753 |
| 135 | Micronodular cirrhosis (HP:0001413) | 1.93852464 |
| 136 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92676539 |
| 137 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89924680 |
| 138 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89924680 |
| 139 | T lymphocytopenia (HP:0005403) | 1.89447399 |
| 140 | Ankle clonus (HP:0011448) | 1.88978875 |
| 141 | Progressive muscle weakness (HP:0003323) | 1.88449675 |
| 142 | Male infertility (HP:0003251) | 1.86835168 |
| 143 | Cone-rod dystrophy (HP:0000548) | 1.85318231 |
| 144 | Hypergammaglobulinemia (HP:0010702) | 1.85253359 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.84980278 |
| 146 | Encephalitis (HP:0002383) | 1.83808829 |
| 147 | Reduced antithrombin III activity (HP:0001976) | 1.83764693 |
| 148 | Arterial thrombosis (HP:0004420) | 1.83596660 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.81942119 |
| 150 | Osteomyelitis (HP:0002754) | 1.81933292 |
| 151 | Acute hepatic failure (HP:0006554) | 1.80656010 |
| 152 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80076517 |
| 153 | Ileus (HP:0002595) | 1.79988864 |
| 154 | Growth hormone excess (HP:0000845) | 1.79977172 |
| 155 | Inflammation of the large intestine (HP:0002037) | 1.79164127 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.78349395 |
| 157 | Failure to thrive in infancy (HP:0001531) | 1.77978695 |
| 158 | Gastrointestinal infarctions (HP:0005244) | 1.77665411 |
| 159 | Hyperphosphatemia (HP:0002905) | 1.77103098 |
| 160 | Abnormality of chloride homeostasis (HP:0011422) | 1.76515076 |
| 161 | Conjunctival telangiectasia (HP:0000524) | 1.76098394 |
| 162 | Urticaria (HP:0001025) | 1.75513274 |
| 163 | Right ventricular cardiomyopathy (HP:0011663) | 1.74075027 |
| 164 | Menstrual irregularities (HP:0000858) | 1.74055411 |
| 165 | Ovoid vertebral bodies (HP:0003300) | 1.73871918 |
| 166 | Hypotension (HP:0002615) | 1.73755081 |
| 167 | Loss of speech (HP:0002371) | 1.72693935 |
| 168 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.72237320 |
| 169 | Granulocytopenia (HP:0001913) | 1.71872547 |
| 170 | Prominent metopic ridge (HP:0005487) | 1.71306167 |
| 171 | Abnormality of T cell number (HP:0011839) | 1.70756812 |
| 172 | Thyroiditis (HP:0100646) | 1.70595004 |
| 173 | Joint stiffness (HP:0001387) | 1.70000912 |
| 174 | Cheilitis (HP:0100825) | 1.68759421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.99785221 |
| 2 | PASK | 3.48530521 |
| 3 | RIPK4 | 3.29015543 |
| 4 | TAOK3 | 2.96524855 |
| 5 | ERN1 | 2.83903208 |
| 6 | MAP4K1 | 2.77325124 |
| 7 | INSRR | 2.50224797 |
| 8 | TGFBR2 | 2.12994725 |
| 9 | EPHA2 | 2.04116783 |
| 10 | MET | 2.00691247 |
| 11 | ZAP70 | 1.99091774 |
| 12 | TNK2 | 1.99063803 |
| 13 | STK10 | 1.97206019 |
| 14 | MAP2K2 | 1.95703893 |
| 15 | MAP3K2 | 1.86405454 |
| 16 | HIPK2 | 1.74705286 |
| 17 | TAOK1 | 1.70536368 |
| 18 | FLT3 | 1.70494778 |
| 19 | TESK2 | 1.69359451 |
| 20 | GRK6 | 1.67003128 |
| 21 | TRIB3 | 1.64205831 |
| 22 | MST4 | 1.59593092 |
| 23 | TBK1 | 1.54703552 |
| 24 | ITK | 1.54411635 |
| 25 | JAK3 | 1.52810737 |
| 26 | MST1R | 1.52060875 |
| 27 | PRPF4B | 1.51125705 |
| 28 | FGFR4 | 1.50980973 |
| 29 | BLK | 1.49700257 |
| 30 | MAP3K10 | 1.48752494 |
| 31 | IRAK4 | 1.45984598 |
| 32 | PKN2 | 1.43195718 |
| 33 | PIK3CG | 1.40865969 |
| 34 | PRKG2 | 1.40680788 |
| 35 | MAPKAPK3 | 1.36525436 |
| 36 | NME2 | 1.36036193 |
| 37 | TYK2 | 1.34539653 |
| 38 | SIK1 | 1.33757645 |
| 39 | SMG1 | 1.33172986 |
| 40 | PTK6 | 1.33098626 |
| 41 | CSF1R | 1.28643946 |
| 42 | BTK | 1.27148112 |
| 43 | IRAK3 | 1.22760829 |
| 44 | EEF2K | 1.22753041 |
| 45 | FRK | 1.21224205 |
| 46 | PDPK1 | 1.20062453 |
| 47 | PDK1 | 1.18686950 |
| 48 | TEC | 1.15735745 |
| 49 | FES | 1.12353812 |
| 50 | NLK | 1.12008511 |
| 51 | PTK2 | 1.10582650 |
| 52 | SCYL2 | 1.09945105 |
| 53 | MARK2 | 1.08341714 |
| 54 | TGFBR1 | 1.06972133 |
| 55 | MAP3K1 | 1.06808126 |
| 56 | CSK | 1.02092573 |
| 57 | RET | 0.98380096 |
| 58 | DYRK1B | 0.98228044 |
| 59 | BMPR1B | 0.97877534 |
| 60 | RPS6KB2 | 0.97551131 |
| 61 | RPS6KA2 | 0.96783508 |
| 62 | MAP3K14 | 0.89255967 |
| 63 | DYRK3 | 0.89185855 |
| 64 | LRRK2 | 0.88651465 |
| 65 | HCK | 0.87577996 |
| 66 | CDK12 | 0.87421842 |
| 67 | TXK | 0.87012547 |
| 68 | BCKDK | 0.86082225 |
| 69 | IKBKE | 0.85835950 |
| 70 | LMTK2 | 0.85512268 |
| 71 | PRKD2 | 0.83257288 |
| 72 | RIPK1 | 0.82930073 |
| 73 | LYN | 0.82150309 |
| 74 | TSSK6 | 0.81294165 |
| 75 | MATK | 0.80526528 |
| 76 | JAK2 | 0.78997184 |
| 77 | TESK1 | 0.78209147 |
| 78 | SIK3 | 0.78193159 |
| 79 | KDR | 0.73925721 |
| 80 | PIK3CA | 0.72641353 |
| 81 | MAP3K13 | 0.72504321 |
| 82 | LCK | 0.72062169 |
| 83 | CHUK | 0.70533603 |
| 84 | BMPR2 | 0.70411207 |
| 85 | SYK | 0.65888131 |
| 86 | NUAK1 | 0.64109825 |
| 87 | NEK6 | 0.63423206 |
| 88 | RPS6KC1 | 0.63405087 |
| 89 | RPS6KL1 | 0.63405087 |
| 90 | AKT3 | 0.63293728 |
| 91 | MAP2K6 | 0.61613689 |
| 92 | MAP2K3 | 0.60901281 |
| 93 | ICK | 0.60147526 |
| 94 | MAP3K6 | 0.59576014 |
| 95 | GRK7 | 0.58953399 |
| 96 | EPHA3 | 0.58856754 |
| 97 | PAK4 | 0.57938531 |
| 98 | PRKCQ | 0.55951377 |
| 99 | DAPK2 | 0.55296917 |
| 100 | JAK1 | 0.55155846 |
| 101 | PDGFRB | 0.54939660 |
| 102 | EPHB1 | 0.54235462 |
| 103 | MYLK | 0.53142139 |
| 104 | FGFR3 | 0.52903966 |
| 105 | MAP3K3 | 0.52517463 |
| 106 | RPS6KA6 | 0.50964929 |
| 107 | PRKCI | 0.50393051 |
| 108 | PIM2 | 0.49985249 |
| 109 | ACVR1B | 0.49885005 |
| 110 | RPS6KA4 | 0.49306774 |
| 111 | MAP3K8 | 0.49213216 |
| 112 | KSR2 | 0.48763164 |
| 113 | IKBKB | 0.48463724 |
| 114 | PRKD3 | 0.48455060 |
| 115 | BMX | 0.47136085 |
| 116 | GRK5 | 0.46564030 |
| 117 | CAMKK1 | 0.45744363 |
| 118 | DAPK1 | 0.44819146 |
| 119 | BRSK2 | 0.44038014 |
| 120 | SIK2 | 0.44023635 |
| 121 | MAPK11 | 0.43574493 |
| 122 | FER | 0.42578199 |
| 123 | FYN | 0.42100959 |
| 124 | PTK2B | 0.42083831 |
| 125 | MAPK12 | 0.41855735 |
| 126 | MAP3K5 | 0.40973043 |
| 127 | NME1 | 0.38751229 |
| 128 | KIT | 0.38070417 |
| 129 | CAMKK2 | 0.37405410 |
| 130 | CDC42BPA | 0.37153757 |
| 131 | NEK2 | 0.37110823 |
| 132 | NTRK1 | 0.36791623 |
| 133 | MAP3K11 | 0.36646892 |
| 134 | MAPKAPK2 | 0.35735184 |
| 135 | WNK3 | 0.35289007 |
| 136 | IRAK1 | 0.35281462 |
| 137 | EIF2AK3 | 0.34304875 |
| 138 | PIM1 | 0.32891053 |
| 139 | MAPK3 | 0.31778367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 6.21852492 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.83010965 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.21832156 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.11071085 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.00673824 |
| 6 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.82436256 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.74070814 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.71814174 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53657176 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39407288 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.38020228 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 2.12542581 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.02341032 |
| 14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.97825835 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.96068287 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.95620069 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91247377 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.74991841 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70319982 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.66532855 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63195955 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62009316 |
| 23 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.61015094 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.56524938 |
| 25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.47916765 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.42812012 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39603666 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.38729589 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38064698 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.25960862 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24246266 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.16792954 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.15198375 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14102468 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10018354 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07014297 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02243528 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.01782720 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00787265 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99506503 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98171364 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97985855 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94269752 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93626381 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.88034433 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85974545 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85789655 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85227715 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84553936 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83400922 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83342322 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82999752 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81435468 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81301687 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80966741 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80639836 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80363658 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80230509 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79176574 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78663441 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77433482 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75951992 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74998430 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74819771 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74494611 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.74345717 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73061683 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72182330 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71063646 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70883197 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69879990 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69147712 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69147184 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.68541172 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66903005 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66871254 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65959308 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65274517 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64530062 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61248833 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60689705 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60627145 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60608220 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.60022187 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.57553557 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56684137 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.55457659 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55178219 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54733649 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.54223347 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53376790 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.53195353 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52623713 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52538762 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52436582 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.52394392 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51960783 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51331454 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50225842 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49516841 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.49031030 |
| 102 | Salivary secretion_Homo sapiens_hsa04970 | 0.45655132 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45482998 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45314625 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44683962 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43325716 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.43097279 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42245625 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42204423 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41966366 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41929128 |
| 112 | Influenza A_Homo sapiens_hsa05164 | 0.41648829 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41053276 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.40413149 |
| 115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.39831936 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.39052529 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37806417 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37797038 |
| 119 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37468480 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37026047 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.35496292 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34715392 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33601447 |
| 124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32857087 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32816591 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32266609 |
| 127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31751449 |
| 128 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31378835 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30676531 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28910154 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.27135421 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25892828 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25144973 |
| 134 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24810763 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23604127 |
| 136 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21200449 |
| 137 | Shigellosis_Homo sapiens_hsa05131 | 0.20426226 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.18870324 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18384702 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17061568 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.16270880 |

